Halyard Health, Inc. (HYH) Shares Bought by Principal Financial Group Inc.

Principal Financial Group Inc. lifted its stake in Halyard Health, Inc. (NYSE:HYH) by 0.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 225,488 shares of the medical instruments supplier’s stock after buying an additional 1,527 shares during the quarter. Principal Financial Group Inc. owned approximately 0.48% of Halyard Health worth $10,154,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in HYH. Riverhead Capital Management LLC lifted its holdings in shares of Halyard Health by 88.1% in the second quarter. Riverhead Capital Management LLC now owns 3,197 shares of the medical instruments supplier’s stock worth $126,000 after buying an additional 1,497 shares in the last quarter. LS Investment Advisors LLC lifted its holdings in shares of Halyard Health by 16.1% in the second quarter. LS Investment Advisors LLC now owns 4,017 shares of the medical instruments supplier’s stock worth $158,000 after buying an additional 556 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in shares of Halyard Health by 17.7% in the second quarter. Victory Capital Management Inc. now owns 4,732 shares of the medical instruments supplier’s stock worth $186,000 after buying an additional 711 shares in the last quarter. QS Investors LLC lifted its holdings in shares of Halyard Health by 305.6% in the second quarter. QS Investors LLC now owns 5,176 shares of the medical instruments supplier’s stock worth $203,000 after buying an additional 3,900 shares in the last quarter. Finally, Quotient Investors LLC purchased a new position in shares of Halyard Health in the third quarter worth $203,000. 90.31% of the stock is currently owned by hedge funds and other institutional investors.

Several research firms have recently commented on HYH. Stifel Nicolaus reissued a “buy” rating and issued a $52.00 target price on shares of Halyard Health in a report on Friday, November 3rd. Zacks Investment Research downgraded shares of Halyard Health from a “hold” rating to a “sell” rating in a report on Tuesday, October 10th. KeyCorp reissued a “hold” rating on shares of Halyard Health in a report on Tuesday, October 17th. TheStreet downgraded shares of Halyard Health from a “b-” rating to a “c+” rating in a report on Monday, October 30th. Finally, BidaskClub raised shares of Halyard Health from a “hold” rating to a “buy” rating in a report on Saturday, August 19th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $44.00.

Shares of Halyard Health, Inc. (NYSE:HYH) opened at $48.41 on Monday. Halyard Health, Inc. has a 1 year low of $35.24 and a 1 year high of $50.99. The firm has a market cap of $2,267.35, a price-to-earnings ratio of 23.16, a P/E/G ratio of 2.62 and a beta of 1.77. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19.

Halyard Health (NYSE:HYH) last announced its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.13. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The company had revenue of $401.40 million for the quarter, compared to analysts’ expectations of $394.54 million. During the same quarter in the previous year, the business posted $0.48 earnings per share. Halyard Health’s quarterly revenue was up 1.0% on a year-over-year basis. analysts forecast that Halyard Health, Inc. will post 2.08 EPS for the current fiscal year.

WARNING: This story was first reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://www.com-unik.info/2017/12/04/halyard-health-inc-hyh-shares-bought-by-principal-financial-group-inc.html.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Want to see what other hedge funds are holding HYH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Halyard Health, Inc. (NYSE:HYH).

Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)

What are top analysts saying about Halyard Health Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Halyard Health Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit